Loading…

Decorin attenuates hypertrophic scar fibrosis via TGFβ/Smad signalling

The management of hypertrophic scars (HSs), characterized by excessive collagen production, involves various nonsurgical and surgical interventions. However, the absence of a well‐defined molecular mechanism governing hypertrophic scarring has led to less‐than‐ideal results in clinical antifibrotic...

Full description

Saved in:
Bibliographic Details
Published in:Experimental dermatology 2024-07, Vol.33 (7), p.e15133-n/a
Main Authors: Cui, Jiangtao, Zhang, Shiyi, Acharya, Kiran, Xu, Yan, Guo, Heng, Li, Tong, Fu, Donghe, Yang, Zizhen, Hou, Lingnan, Xing, Xiaotao, Hu, Xiaoyi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2433-3c9dcf7908adf6d792f2a4a08e969931d01d75147f549d671d560835028635c63
container_end_page n/a
container_issue 7
container_start_page e15133
container_title Experimental dermatology
container_volume 33
creator Cui, Jiangtao
Zhang, Shiyi
Acharya, Kiran
Xu, Yan
Guo, Heng
Li, Tong
Fu, Donghe
Yang, Zizhen
Hou, Lingnan
Xing, Xiaotao
Hu, Xiaoyi
description The management of hypertrophic scars (HSs), characterized by excessive collagen production, involves various nonsurgical and surgical interventions. However, the absence of a well‐defined molecular mechanism governing hypertrophic scarring has led to less‐than‐ideal results in clinical antifibrotic treatments. Therefore, our study focused on the role of decorin (DCN) and its regulatory role in the TGF‐β/Smad signalling pathway in the development of HSs. In our research, we observed a decrease in DCN expression within hypertrophic scar tissue and its derived cells (HSFc) compared to that in normal tissue. Then, the inhibitory effect of DCN on collagen synthesis was confirmed in Fc and HSFc via the detection of fibrosis markers such as COL‐1 and COL‐3 after the overexpression and knockdown of DCN. Moreover, functional assessments revealed that DCN suppresses the proliferation, migration and invasion of HSFc. We discovered that DCN significantly inhibits the TGF‐β1/Smad3 pathway by suppressing TGF‐β1 expression, as well as the formation and phosphorylation of Smad3. This finding suggested that DCN regulates the synthesis of collagen‐based extracellular matrix and fibrosis through the TGF‐β1/Smad3 pathway. DCN knockdown siRNA and DCN‐overexpressing lentiviruses.Our research revealed that DCN not only reduces collagen accumulation within HSs but also hinders the proliferation, invasion and migration of HSFc. Moreover, DCN reduced fibrosis by inhibiting the TGF‐β1/Smad3 signalling pathway.
doi_str_mv 10.1111/exd.15133
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3084028489</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3084028489</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2433-3c9dcf7908adf6d792f2a4a08e969931d01d75147f549d671d560835028635c63</originalsourceid><addsrcrecordid>eNp10EtOwzAQBmALgaA8FlwARWIDi9Bx_IqXCGhBqsSCIrGLjO20rtKk2AnQa3EQzoQhwAKJ2czm06-ZH6FDDGc4ztC-mjPMMCEbaIA5QAo8Y5toABJ4ygWwHbQbwgIACyLYNtohEijLZT5A40urG-_qRLWtrTvV2pDM1yvrW9-s5k4nQSuflO7RN8GF5NmpZDoevb8N75bKJMHNalVVrp7to61SVcEefO89dD-6ml5cp5Pb8c3F-STVGSUkJVoaXQoJuTIlN0JmZaaogtxKLiXBBrARDFNRMioNF9gwDjlhkOWcMM3JHjrpc1e-eepsaIulC9pWlapt04WCQE4jprmM9PgPXTSdj_f2iklBBY3qtFc6fhi8LYuVd0vl1wWG4rPdIrZbfLUb7dF3Yve4tOZX_tQZwbAHL66y6_-TiquHyz7yA1qXgiI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3084597474</pqid></control><display><type>article</type><title>Decorin attenuates hypertrophic scar fibrosis via TGFβ/Smad signalling</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Cui, Jiangtao ; Zhang, Shiyi ; Acharya, Kiran ; Xu, Yan ; Guo, Heng ; Li, Tong ; Fu, Donghe ; Yang, Zizhen ; Hou, Lingnan ; Xing, Xiaotao ; Hu, Xiaoyi</creator><creatorcontrib>Cui, Jiangtao ; Zhang, Shiyi ; Acharya, Kiran ; Xu, Yan ; Guo, Heng ; Li, Tong ; Fu, Donghe ; Yang, Zizhen ; Hou, Lingnan ; Xing, Xiaotao ; Hu, Xiaoyi</creatorcontrib><description>The management of hypertrophic scars (HSs), characterized by excessive collagen production, involves various nonsurgical and surgical interventions. However, the absence of a well‐defined molecular mechanism governing hypertrophic scarring has led to less‐than‐ideal results in clinical antifibrotic treatments. Therefore, our study focused on the role of decorin (DCN) and its regulatory role in the TGF‐β/Smad signalling pathway in the development of HSs. In our research, we observed a decrease in DCN expression within hypertrophic scar tissue and its derived cells (HSFc) compared to that in normal tissue. Then, the inhibitory effect of DCN on collagen synthesis was confirmed in Fc and HSFc via the detection of fibrosis markers such as COL‐1 and COL‐3 after the overexpression and knockdown of DCN. Moreover, functional assessments revealed that DCN suppresses the proliferation, migration and invasion of HSFc. We discovered that DCN significantly inhibits the TGF‐β1/Smad3 pathway by suppressing TGF‐β1 expression, as well as the formation and phosphorylation of Smad3. This finding suggested that DCN regulates the synthesis of collagen‐based extracellular matrix and fibrosis through the TGF‐β1/Smad3 pathway. DCN knockdown siRNA and DCN‐overexpressing lentiviruses.Our research revealed that DCN not only reduces collagen accumulation within HSs but also hinders the proliferation, invasion and migration of HSFc. Moreover, DCN reduced fibrosis by inhibiting the TGF‐β1/Smad3 signalling pathway.</description><identifier>ISSN: 0906-6705</identifier><identifier>ISSN: 1600-0625</identifier><identifier>EISSN: 1600-0625</identifier><identifier>DOI: 10.1111/exd.15133</identifier><identifier>PMID: 39045898</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>Cell Movement ; Cell Proliferation ; Cells, Cultured ; Cicatrix, Hypertrophic - metabolism ; Cicatrix, Hypertrophic - pathology ; Collagen ; Collagen Type III - metabolism ; Decorin ; Decorin - metabolism ; Extracellular matrix ; fibroblasts ; Fibroblasts - metabolism ; Fibrosis ; Humans ; hypertrophic scar ; Molecular modelling ; Phosphorylation ; proliferation ; Scars ; Signal Transduction ; Smad protein ; Smad3 protein ; Smad3 Protein - metabolism ; TGF‐β1/Smad3 ; Transforming Growth Factor beta1 - metabolism</subject><ispartof>Experimental dermatology, 2024-07, Vol.33 (7), p.e15133-n/a</ispartof><rights>2024 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>2024 John Wiley &amp; Sons A/S</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2433-3c9dcf7908adf6d792f2a4a08e969931d01d75147f549d671d560835028635c63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39045898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cui, Jiangtao</creatorcontrib><creatorcontrib>Zhang, Shiyi</creatorcontrib><creatorcontrib>Acharya, Kiran</creatorcontrib><creatorcontrib>Xu, Yan</creatorcontrib><creatorcontrib>Guo, Heng</creatorcontrib><creatorcontrib>Li, Tong</creatorcontrib><creatorcontrib>Fu, Donghe</creatorcontrib><creatorcontrib>Yang, Zizhen</creatorcontrib><creatorcontrib>Hou, Lingnan</creatorcontrib><creatorcontrib>Xing, Xiaotao</creatorcontrib><creatorcontrib>Hu, Xiaoyi</creatorcontrib><title>Decorin attenuates hypertrophic scar fibrosis via TGFβ/Smad signalling</title><title>Experimental dermatology</title><addtitle>Exp Dermatol</addtitle><description>The management of hypertrophic scars (HSs), characterized by excessive collagen production, involves various nonsurgical and surgical interventions. However, the absence of a well‐defined molecular mechanism governing hypertrophic scarring has led to less‐than‐ideal results in clinical antifibrotic treatments. Therefore, our study focused on the role of decorin (DCN) and its regulatory role in the TGF‐β/Smad signalling pathway in the development of HSs. In our research, we observed a decrease in DCN expression within hypertrophic scar tissue and its derived cells (HSFc) compared to that in normal tissue. Then, the inhibitory effect of DCN on collagen synthesis was confirmed in Fc and HSFc via the detection of fibrosis markers such as COL‐1 and COL‐3 after the overexpression and knockdown of DCN. Moreover, functional assessments revealed that DCN suppresses the proliferation, migration and invasion of HSFc. We discovered that DCN significantly inhibits the TGF‐β1/Smad3 pathway by suppressing TGF‐β1 expression, as well as the formation and phosphorylation of Smad3. This finding suggested that DCN regulates the synthesis of collagen‐based extracellular matrix and fibrosis through the TGF‐β1/Smad3 pathway. DCN knockdown siRNA and DCN‐overexpressing lentiviruses.Our research revealed that DCN not only reduces collagen accumulation within HSs but also hinders the proliferation, invasion and migration of HSFc. Moreover, DCN reduced fibrosis by inhibiting the TGF‐β1/Smad3 signalling pathway.</description><subject>Cell Movement</subject><subject>Cell Proliferation</subject><subject>Cells, Cultured</subject><subject>Cicatrix, Hypertrophic - metabolism</subject><subject>Cicatrix, Hypertrophic - pathology</subject><subject>Collagen</subject><subject>Collagen Type III - metabolism</subject><subject>Decorin</subject><subject>Decorin - metabolism</subject><subject>Extracellular matrix</subject><subject>fibroblasts</subject><subject>Fibroblasts - metabolism</subject><subject>Fibrosis</subject><subject>Humans</subject><subject>hypertrophic scar</subject><subject>Molecular modelling</subject><subject>Phosphorylation</subject><subject>proliferation</subject><subject>Scars</subject><subject>Signal Transduction</subject><subject>Smad protein</subject><subject>Smad3 protein</subject><subject>Smad3 Protein - metabolism</subject><subject>TGF‐β1/Smad3</subject><subject>Transforming Growth Factor beta1 - metabolism</subject><issn>0906-6705</issn><issn>1600-0625</issn><issn>1600-0625</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp10EtOwzAQBmALgaA8FlwARWIDi9Bx_IqXCGhBqsSCIrGLjO20rtKk2AnQa3EQzoQhwAKJ2czm06-ZH6FDDGc4ztC-mjPMMCEbaIA5QAo8Y5toABJ4ygWwHbQbwgIACyLYNtohEijLZT5A40urG-_qRLWtrTvV2pDM1yvrW9-s5k4nQSuflO7RN8GF5NmpZDoevb8N75bKJMHNalVVrp7to61SVcEefO89dD-6ml5cp5Pb8c3F-STVGSUkJVoaXQoJuTIlN0JmZaaogtxKLiXBBrARDFNRMioNF9gwDjlhkOWcMM3JHjrpc1e-eepsaIulC9pWlapt04WCQE4jprmM9PgPXTSdj_f2iklBBY3qtFc6fhi8LYuVd0vl1wWG4rPdIrZbfLUb7dF3Yve4tOZX_tQZwbAHL66y6_-TiquHyz7yA1qXgiI</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Cui, Jiangtao</creator><creator>Zhang, Shiyi</creator><creator>Acharya, Kiran</creator><creator>Xu, Yan</creator><creator>Guo, Heng</creator><creator>Li, Tong</creator><creator>Fu, Donghe</creator><creator>Yang, Zizhen</creator><creator>Hou, Lingnan</creator><creator>Xing, Xiaotao</creator><creator>Hu, Xiaoyi</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>202407</creationdate><title>Decorin attenuates hypertrophic scar fibrosis via TGFβ/Smad signalling</title><author>Cui, Jiangtao ; Zhang, Shiyi ; Acharya, Kiran ; Xu, Yan ; Guo, Heng ; Li, Tong ; Fu, Donghe ; Yang, Zizhen ; Hou, Lingnan ; Xing, Xiaotao ; Hu, Xiaoyi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2433-3c9dcf7908adf6d792f2a4a08e969931d01d75147f549d671d560835028635c63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Cell Movement</topic><topic>Cell Proliferation</topic><topic>Cells, Cultured</topic><topic>Cicatrix, Hypertrophic - metabolism</topic><topic>Cicatrix, Hypertrophic - pathology</topic><topic>Collagen</topic><topic>Collagen Type III - metabolism</topic><topic>Decorin</topic><topic>Decorin - metabolism</topic><topic>Extracellular matrix</topic><topic>fibroblasts</topic><topic>Fibroblasts - metabolism</topic><topic>Fibrosis</topic><topic>Humans</topic><topic>hypertrophic scar</topic><topic>Molecular modelling</topic><topic>Phosphorylation</topic><topic>proliferation</topic><topic>Scars</topic><topic>Signal Transduction</topic><topic>Smad protein</topic><topic>Smad3 protein</topic><topic>Smad3 Protein - metabolism</topic><topic>TGF‐β1/Smad3</topic><topic>Transforming Growth Factor beta1 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cui, Jiangtao</creatorcontrib><creatorcontrib>Zhang, Shiyi</creatorcontrib><creatorcontrib>Acharya, Kiran</creatorcontrib><creatorcontrib>Xu, Yan</creatorcontrib><creatorcontrib>Guo, Heng</creatorcontrib><creatorcontrib>Li, Tong</creatorcontrib><creatorcontrib>Fu, Donghe</creatorcontrib><creatorcontrib>Yang, Zizhen</creatorcontrib><creatorcontrib>Hou, Lingnan</creatorcontrib><creatorcontrib>Xing, Xiaotao</creatorcontrib><creatorcontrib>Hu, Xiaoyi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cui, Jiangtao</au><au>Zhang, Shiyi</au><au>Acharya, Kiran</au><au>Xu, Yan</au><au>Guo, Heng</au><au>Li, Tong</au><au>Fu, Donghe</au><au>Yang, Zizhen</au><au>Hou, Lingnan</au><au>Xing, Xiaotao</au><au>Hu, Xiaoyi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decorin attenuates hypertrophic scar fibrosis via TGFβ/Smad signalling</atitle><jtitle>Experimental dermatology</jtitle><addtitle>Exp Dermatol</addtitle><date>2024-07</date><risdate>2024</risdate><volume>33</volume><issue>7</issue><spage>e15133</spage><epage>n/a</epage><pages>e15133-n/a</pages><issn>0906-6705</issn><issn>1600-0625</issn><eissn>1600-0625</eissn><abstract>The management of hypertrophic scars (HSs), characterized by excessive collagen production, involves various nonsurgical and surgical interventions. However, the absence of a well‐defined molecular mechanism governing hypertrophic scarring has led to less‐than‐ideal results in clinical antifibrotic treatments. Therefore, our study focused on the role of decorin (DCN) and its regulatory role in the TGF‐β/Smad signalling pathway in the development of HSs. In our research, we observed a decrease in DCN expression within hypertrophic scar tissue and its derived cells (HSFc) compared to that in normal tissue. Then, the inhibitory effect of DCN on collagen synthesis was confirmed in Fc and HSFc via the detection of fibrosis markers such as COL‐1 and COL‐3 after the overexpression and knockdown of DCN. Moreover, functional assessments revealed that DCN suppresses the proliferation, migration and invasion of HSFc. We discovered that DCN significantly inhibits the TGF‐β1/Smad3 pathway by suppressing TGF‐β1 expression, as well as the formation and phosphorylation of Smad3. This finding suggested that DCN regulates the synthesis of collagen‐based extracellular matrix and fibrosis through the TGF‐β1/Smad3 pathway. DCN knockdown siRNA and DCN‐overexpressing lentiviruses.Our research revealed that DCN not only reduces collagen accumulation within HSs but also hinders the proliferation, invasion and migration of HSFc. Moreover, DCN reduced fibrosis by inhibiting the TGF‐β1/Smad3 signalling pathway.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>39045898</pmid><doi>10.1111/exd.15133</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0906-6705
ispartof Experimental dermatology, 2024-07, Vol.33 (7), p.e15133-n/a
issn 0906-6705
1600-0625
1600-0625
language eng
recordid cdi_proquest_miscellaneous_3084028489
source Wiley-Blackwell Read & Publish Collection
subjects Cell Movement
Cell Proliferation
Cells, Cultured
Cicatrix, Hypertrophic - metabolism
Cicatrix, Hypertrophic - pathology
Collagen
Collagen Type III - metabolism
Decorin
Decorin - metabolism
Extracellular matrix
fibroblasts
Fibroblasts - metabolism
Fibrosis
Humans
hypertrophic scar
Molecular modelling
Phosphorylation
proliferation
Scars
Signal Transduction
Smad protein
Smad3 protein
Smad3 Protein - metabolism
TGF‐β1/Smad3
Transforming Growth Factor beta1 - metabolism
title Decorin attenuates hypertrophic scar fibrosis via TGFβ/Smad signalling
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T03%3A02%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decorin%20attenuates%20hypertrophic%20scar%20fibrosis%20via%20TGF%CE%B2/Smad%20signalling&rft.jtitle=Experimental%20dermatology&rft.au=Cui,%20Jiangtao&rft.date=2024-07&rft.volume=33&rft.issue=7&rft.spage=e15133&rft.epage=n/a&rft.pages=e15133-n/a&rft.issn=0906-6705&rft.eissn=1600-0625&rft_id=info:doi/10.1111/exd.15133&rft_dat=%3Cproquest_cross%3E3084028489%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2433-3c9dcf7908adf6d792f2a4a08e969931d01d75147f549d671d560835028635c63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3084597474&rft_id=info:pmid/39045898&rfr_iscdi=true